| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1109
|
30.06 | 214.4B | 7.28 | 0.64 | 6.18 | 8.7% | 4.8% | 78 | 75 | 59.50 | +72.5% | 66 | 0.99 |
|
1113
|
45.30 | 158.5B | 14.24 | 0.39 | 9.27 | 2.4% | 7.1% | 76 | 58 | 103.15 | +88.1% | 90 | 0.14 |
|
0017
|
6.59 | 16.6B | — | 0.08 | — | 1.7% | 5.2% | 74 | 68 | 19.77 | +122.0% | 66 | 0.77 |
|
0688
|
12.53 | 137.1B | 9.32 | 0.30 | 12.12 | 3.0% | 4.4% | 71 | 65 | 31.72 | +98.0% | 57 | 0.64 |
|
0001
|
70.50 | 270.0B | 22.80 | 0.48 | 5.97 | 4.6% | 5.6% | 70 | 54 | 154.34 | +88.0% | 75 | 0.59 |
|
0101
|
6.98 | 36.3B | 20.11 | 0.27 | 16.96 | 3.1% | 5.7% | 68 | 62 | 17.47 | +96.1% | 51 | 0.40 |
|
0823
|
38.72 | 101.7B | — | 0.68 | — | 4.2% | 6.3% | 66 | 54 | 74.14 | +51.2% | 48 | 0.38 |
|
0016
|
116.20 | 336.7B | 17.68 | 0.54 | 13.39 | 3.4% | 7.7% | 63 | 45 | 162.14 | +25.3% | 72 | 0.17 |
|
0012
|
26.86 | 130.0B | 23.00 | 0.40 | 20.29 | 1.1% | 7.6% | 62 | 45 | 51.35 | +53.8% | 58 | 0.25 |
|
0083
|
10.34 | 99.1B | 24.66 | 0.58 | 20.65 | 1.5% | 8.0% | 59 | 34 | 11.78 | +8.9% | 96 | 0.02 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.